ChargePoint Technology

ChargePoint Technology

ChargePoint Technology Ltd was formed over a decade ago following the 1997 development of its first valve, co-created with Glaxo Pharmaceuticals. That patented split butterfly valve remains the core of the product line, now augmented with single-use powder packaging, fluid handling, and robotic powder-handling systems. The company serves customers in pharmaceutical, biopharmaceutical, and chemical powder manufacturing. The company's portfolio covers four main product areas: powder containment (including the AseptiSafe® and PharmaSafe® valve ranges), aseptic powder transfer, single-use powder packaging (ChargeBag® PE-S and ChargeBag® XL), and fluid management (the Terracon™ and TerraPure® lines). Geographic reach spans Europe and North America, with manufacturing and service facilities in Liverpool (UK), New Jersey, and Boston. May 2026: Published guidance on navigating Annex 1 compliance for aseptic process validation. ChargePoint maintains three physical locations for manufacturing, sales, and service. The Liverpool site handles global manufacturing and support; the New Jersey office provides sales and service for the US; the Boston site (operating as Terracon Corp.) adds a manufacturing base. The AfterCare team supplies installation, spare parts, maintenance packages, and training. No professionals count or AUM is disclosed. The company's structural differentiator is its concentrated product scope: it builds nothing but containment and transfer equipment for a single regulated industry. That focus lets it own a small, defensible niche—split butterfly valves for pharma—where switching costs are high and validation timelines are long.